Search results
You searched for:
Found 37 results
Sorting options:
Date: 21/10/2026 Location: Other
Cytisine is a new, nicotine-free smoking cessation aid. Like varenicline, cytisine is a selective, partial agonist of the α4β2 nicotinic acetylcholine receptors. As this is the first new chemical entity for smoking cessation approved in Australia for almost
1 Educational activity hour
Professionalism
Addressing health inequities
Date: 07/05/2026 Location: Other
Thiswebinarfocuses on practical, evidence‑based strategies to supportappropriate antibioticprescribing for acute respiratory infections in primary care. Participants will explore the common pressures that influence prescribing decisions, from patient
0.5 Educational activity hour
0.5 Performance review hour
Professionalism
Ethical practice
Date: 22/04/2026 Location: Other
Developed by the Australian Commission on Safety and Quality in Health Care, this module aims to strengthen clinicians’ understanding of Chronic Obstructive Pulmonary Disease (COPD) by guiding you through using your own practice data to identify gaps,
2 Educational activity hours
5 Performance review hours
10 Outcome measurement hours
Culturally safe practice
Professionalism
Ethical practice
Addressing health inequities
Date: 29/08/2026 Location: Other
Cardiac Amyloidosis: Real World Progress, Results andamp; Remaining Gaps is a multidisciplinary specialist program examining advances and continuing challenges in the recognition and management of transthyretin amyloid cardiomyopathy (ATTR-CM).Although
1.25 Educational activity hours
1.75 Performance review hours
5 Outcome measurement hours
Culturally safe practice
Professionalism
Ethical practice
Addressing health inequities
Date: 01/01/2026 Location: Other
The TGA (2023) states that ‘unapproved medicine approvals have significantly increased by 9.3% for Special Access Scheme B and 14% for Authorised Prescriber applications, primarily due to the sustained growth in medicinal cannabis products’. With
1.5 Educational activity hours
Professionalism
Ethical practice
Date: 01/01/2026 Location: Other
This medicinal cannabis course focuses on the major phytocannabinoids: THC and CBD. The course provides a comprehensive examination of the two main cannabinoids, tetrahydrocannabinol (THC) and cannabidiol (CBD). It distinguishes between their main actions and
4 Educational activity hours
5 Performance review hours
Professionalism
Ethical practice
Date: 28/08/2026 Location: Other
HER2 in NSCLC: What Matters Now? Treatment, Testing and Sequencing is a 90-minute online masterclass examining the rapidly evolving management of HER2-driven non-small cell lung cancer.Led by Australian and international experts in medical oncology and
1.25 Educational activity hours
1.75 Performance review hours
5 Outcome measurement hours
Culturally safe practice
Professionalism
Ethical practice
Addressing health inequities
Date: 06/05/2026 Location: Other
An unknown, but likely growing number of Australian men are using finasteride to treat androgenic alopecia (male pattern hair loss), many through online prescribing services.Known side effects of finasteride include loss of libido, erectile dysfunction,
1 Educational activity hour
Culturally safe practice
Ethical practice
Professionalism
Date: 01/01/2026 Location: Other
This outcome improvement activity relates to medicinal cannabis and chronic pain and enables doctors to review and enhance their current practice for patients who may benefit from medicinal cannabis in chronic pain. This activity will guide you to compare and
8.5 Outcome measurement hours
Professionalism
Ethical practice
Date: 01/01/2026 Location: Other
This outcome improvement activity relates to medicinal cannabis - endometriosis and enables doctors to review and enhance their current practice for patients who may benefit from the use of medicinal cannabis to treat endometriosis. The activity will guide
8.5 Outcome measurement hours
Professionalism
Ethical practice